Inspire Advisors, LLC Adma Biologics, Inc. Transaction History

Inspire Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$17.6 - $24.51 $27,456 - $38,235	1,560 Added 7.1%	23,547 $428,000
Q1 2025 May 07, 2025	SELL	$15.44 - $20.61 $6,284 - $8,388	-407 Reduced 1.82%	21,987 $436,000
Q4 2024 Feb 07, 2025	BUY	$15.62 - $22.62 $23,929 - $34,653	1,532 Added 7.34%	22,394 $384,000
Q3 2024 Oct 17, 2024	BUY	$11.21 - $20.03 $233,863 - $417,865	20,862 New	20,862 $417,000

400

205M

3.06M

1.88M

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.06B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Inspire Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Advisors, LLC with notifications on news.